Combining two different immunotherapy treatments could dramatically improve lymphoma survival, according to a University study.
Funded by Cancer Research UK and published in Cancer Cell, the study tested different combinations of antibodies in the laboratory to see how they interact with each other and what effect this has on how the immune system fights cancer.
For more information on this study, please view the news article on the University website.
